Use of Adjunctive Therapy in Acute Kawasaki Disease in Latin America
Open Access
- 15 September 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 8, 442
- https://doi.org/10.3389/fped.2020.00442
Abstract
Objective: To characterize the use of adjunctive therapy in Kawasaki disease (KD) in Latin America. Methods: The study included 1,418 patients from the Latin American KD Network (REKAMLATINA) treated for KD between January 1, 2009, and May 31, 2017. Results: Of these patients, 1,152 received only a single dose of IVIG, and 266 received additional treatment. Age at onset was similar in both groups (median 2 vs. 2.2 years, respectively). The majority of patients were male (58 vs. 63.9%) and were hospitalized with the first 10 days of fever (85.1 vs. 84.2%). The most common adjunctive therapy administered was steroids for IVIG-resistance, followed by additional doses of IVIG. The use of biologics such as infliximab was limited. KD patients who received adjunctive therapy were more likely to have a lower platelet count and albumin level as well as a higher Z score of the coronary arteries. Conclusion: This is the first report of adjunctive therapies for KD across Latin America. IVIG continues to be the initial and resistance treatment, however, steroids are also used and to a lesser extent, biological therapy such as infliximab. Future studies should address the barriers to therapy in children with acute KD throughout Latin America.This publication has 23 references indexed in Scilit:
- Histopathological aspects of cardiovascular lesions in Kawasaki diseaseInternational Journal of Rheumatic Diseases, 2017
- Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart AssociationCirculation, 2017
- High Risk of Coronary Artery Aneurysms in Infants Younger than 6 Months of Age with Kawasaki DiseaseThe Journal of Pediatrics, 2017
- Kawasaki Disease in Latin American Children: Past, Current, and Future ChallengesJournal of the Pediatric Infectious Diseases Society, 2014
- Specificity of regulatory T cells that modulate vascular inflammationAutoimmunity, 2013
- Revisión de la enfermedad de Kawasaki en México, desde la perspectiva de las publicaciones médicas (enero de 1977 a mayo de 2012)Archivos de Cardiología de México, 2013
- The role of TGF-β and myofibroblasts in the arteritis of Kawasaki diseaseHuman Pathology, 2013
- Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistanceHuman Immunology, 2010
- Resistance to Intravenous Immunoglobulin in Children with Kawasaki DiseaseThe Journal of Pediatrics, 2008
- Clinical spectrum of Kawasaki disease in infants younger than 6 months of ageThe Journal of Pediatrics, 1986